Case Reports
doi: 10.1016/s0090-4295(99)00409-4.
Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan
Affiliations
- PMID: 10754170
- DOI: 10.1016/s0090-4295(99)00409-4
Item in Clipboard
Case Reports
Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan
Urology.
2000 Feb.
Free article
Abstract
The clinical utility of positron emission tomography (PET) in renal cell carcinoma (RCC) has not been determined. We describe a case in which metastatic RCC undetected by traditional staging methods was accurately staged by PET. A 77-year-old man presented with a 20-lb weight loss and bilateral renal masses. Plain radiographs, bone scintigraphy, and alkaline phosphatase were normal. PET imaging confirmed the right renal mass and revealed several metastatic bone lesions, confirmed by biopsy. The patient died 7 months after diagnosis. This case illustrates the potential superiority of PET in evaluating skeletal metastases of RCC.
Similar articles
-
Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.Rev Esp Med Nucl. 2011 Mar-Apr;30(2):94-6. doi: 10.1016/j.remn.2010.10.008. Epub 2011 Feb 20. Rev Esp Med Nucl. 2011. PMID: 21342722
-
[Case of renal cell carcinoma with intertrabecular vertebral metastases detected f-18 fluorodeoxyglucose positron emission tomography and MRI].Hinyokika Kiyo. 2014 Jan;60(1):29-32. Hinyokika Kiyo. 2014. PMID: 24594770 Japanese.
-
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.Nucl Med Commun. 2011 Apr;32(4):265-72. doi: 10.1097/MNM.0b013e3283442e3b. Nucl Med Commun. 2011. PMID: 21301376
-
Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002. Semin Nucl Med. 2009. PMID: 19801221 Review.
-
[A Case of Metastatic Tubulocystic Carcinoma of the Kidney Treated with Molecularly Targeted Therapy].Hinyokika Kiyo. 2016 Nov;62(11):569-574. doi: 10.14989/ActaUrolJap_62_11_569. Hinyokika Kiyo. 2016. PMID: 27919134 Review. Japanese.
Cited by
-
Staging of renal cell carcinoma.Eur Radiol. 2007 Sep;17(9):2268-77. doi: 10.1007/s00330-006-0554-1. Epub 2007 Feb 22. Eur Radiol. 2007. PMID: 17318606 Review.
-
Functional imaging of renal cell carcinoma.Nat Rev Urol. 2010 May;7(5):258-66. doi: 10.1038/nrurol.2010.40. Nat Rev Urol. 2010. PMID: 20448659 Review.
-
Positron emission tomography in uro-oncology.Cancer Imaging. 2005 Jan 17;5(1):1-7. doi: 10.1102/1470-7330.2005.0001. Cancer Imaging. 2005. PMID: 16154810 Free PMC article.
-
[Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].Urologe A. 2004 Nov;43(11):1397-409. doi: 10.1007/s00120-004-0714-3. Urologe A. 2004. PMID: 15502907 German.
-
Clinical effectiveness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in management of renal cell carcinoma: a single institution experience.World J Nucl Med. 2015 Jan-Apr;14(1):36-40. doi: 10.4103/1450-1147.150535. World J Nucl Med. 2015. PMID: 25709543 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
